Development of a New Method for Liver Stiffness Measurement Using FibroScan
M148 - Development of a New Method for Liver Stiffness Measurement Using FibroScan
Echosens
114 participants
Nov 8, 2024
INTERVENTIONAL
Conditions
Summary
This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.
Eligibility
Inclusion Criteria3
- Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.
- Adult patient able to give his written consent
- Patient affiliated to the French Social Security system
Exclusion Criteria3
- Vulnerable patients
- Patients with liver ascites
- Patients with heart failure
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients #1 to #25: Exam 1: Examination with Research FibroScan. Exam 2: Examination with the Reference FibroScan at the same measurement point and with the same probe used for the Exam 1. Patients #26 to #75: Exam 1: Examination with the Research or Reference FibroScan. Exam 2: Examination with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exam 1. Patients #76 to #114: Exams 1 \& 2: 2 consecutive examinations with the Research or Reference FibroScan. Exams 3 \& 4: 2 consecutive examinations with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exams 1 \& 2.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06519331